Home / Stocks / BACPHAR
Back to all stocks
BSE · BACPHAR

Bacil Pharma Ltd. (BACPHAR) Share Price

Sector: Healthcare · ISIN: INE711D01018

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,019
of 5,047 stocks
▼ 121W▼ 2031M
Peak #3,595 · 02 Oct 2026

Bacil Pharma Ltd. is a microcap company in the Healthcare space and has a widely-held ownership base, with promoters at just 0%, trades at a moderate earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap
23.57 Cr
P/E Ratio
15.20
P/B Ratio
0.40
ROE
6.27%
ROCE
3.99%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
RevenueRs 0Rs 0Rs 0Rs 0
Net Profit9.05 L-1.91 L62.16 L3.92 L
EPS0.060.220.440.03
Operating Profit3.25 L6.64 L-7.45 L3.92 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
0.00%
Public
100.00%

PUBLIC BREAKDOWN

Individuals
78.84%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
20 Sep 2012OtherGeneral
12 Sep 2011OtherGeneral
09 Sep 2010OtherGeneral
10 Sep 2009OtherGeneral
11 Sep 2008OtherGeneral

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs